Rejected at 11:18 a.m. Apr, 04, 2024 ] by Cameron
Author: skyemonroes
Related Note: 1499358446751
Rationale for change

Add cloze to test knowledge on drug class of sildenafil/tadalafil.

Rejection reason

Comments, cloze is weak and ambiguous without obvious hint

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Low/HighYield::1-HighYield #PANCE::EOR::IM #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#B&B::20_Pulm::01_Embryology_Anatomy_and_Physiology::08_Pulmonary_Hypertension::Extra #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::^Other::^EXPN #AK_Step1_v12::#Bootcamp::Cardiology::07_Vasodilation_and_Vasoconstriction::04_Pharmacologic_Targets #AK_Step1_v12::#Pixorize::03_Pharmacology::19_Reproductive_Pharm::13_PDE-5_Inhibitors_(Sildenafil/Vardenafil/Tadalafil) #AK_Step2_v12::#SketchyIM::03_Pulmonology::04_Pulmonary_Vasculature_DIsorders::01_Pulmonary_Hypertension #AK_Step1_v12::#Physeo::09_Pharm::12_Reproductive::11_Phosphodiesterase_type_5_inhibitors #AK_Step1_v12::#Bootcamp::Pulmonology::08_Lung_Pathology_Special_Topics::02_Pulmonary_Hypertension #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::16_Phosphodiesterase_inhibitors::*PDE_5_Inhibitors #AK_Step1_v12::#B&B::22_Repro::06_Male_Disorders::01_Penile_Disorders::Extra #AK_Step1_v12::#OME::PreClinical::General_Physiology::Smooth_Muscle #AK_Step1_v12::#FirstAid::15_Repro::05_Pharm::*PDE5_Inhibitors #PANCE::PULM::pulmonary_circulation #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::05_Pulmonary_HTN_Drugs #AK_Step1_v12::#AMBOSS::V_0GMi #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::03_Other::01_Pulmonary_Hypertension::Extra #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::17_Phosphodiesterase_Inhibitors #AK_Step1_v12::#SketchyPharm::04_Smooth_Muscle::01_Vasoactive::03_Prostaglandins,_Prostacyclin,_Bosentan,_PDE5_Inhibitors #AK_Step3_v12::#UWorld::6364 #AK_Step1_v12::#AMBOSS #AK_Step1_v12::#AMBOSS::lcavcj